Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 2/20 | 0.40 |
| ▸ | HPGDS | O60760 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
| ▸ | NPR1 | P16066 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21094410 | 0.89 | NPC1 (0.40) | NPC1RAB9AATM | |
| SCHEMBL21094394 | 0.88 | NPC1 (0.41) | NPC1RAB9AATMBRD4EPHX2 | |
| SCHEMBL21094393 | 0.85 | NPC1 (0.40) | NPC1RAB9AATM | |
| SCHEMBL21094397 | 0.84 | NPC1 (0.39) | HPGDSNPC1RAB9AATM | |
| SCHEMBL21094086 | 0.83 | NPC1 (0.40) | NPC1RAB9AATMRXFP1 | |
| SCHEMBL21093670 | 0.83 | TRPM8 (0.43) | NPC1RAB9AATM | |
| SCHEMBL21094386 | 0.83 | RIPK1 (0.38) | GRIN2BNPC1RAB9AATM | |
| SCHEMBL21094405 | 0.78 | PKM (0.40) | NPC1RAB9AATM | |
| SCHEMBL21093657 | 0.76 | CA1 (0.43) | NPC1RAB9A | |
| SCHEMBL20835498 | 0.72 | CHRNB4 (0.46) | ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019112024-A1 | PYRROLIDINE COMPOUND | キッセイ薬品工業株式会社 | 2019-06-13 | — | — | WO | disclosed |